Evidence map›Paper›PMID 28921763›Full record

ArticleAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine2018

Implementation and Preliminary Clinical Outcomes of a Pharmacist-managed Venous Thromboembolism Clinic for Patients Treated With Rivaroxaban Post Emergency Department Discharge.

Baely M DiRenzo, Daren M Beam, Jeffrey A Kline, Karishma S Deodhar, Zachary A Weber, Christie M Davis, Todd A Walroth

Open access · bronzeAbstract read
In one paragraph

Article in Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Effect of pharmacist care on clinical outcomes and therapy optimization in perioperative settings: A systematic review.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2024
    Pooled it
  2. Pooled it
  3. Systematic Review of Real-World Studies Evaluating Characteristics Associated With or Programs Designed to Facilitate Outpatient Management of Deep Vein Thrombosis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2018
    Pooled it
  4. Article
  5. JTH in Clinic: management of low-risk pulmonary embolism.Journal of thrombosis and haemostasis : JTH · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Baely M DiRenzoDepartment of Pharmacy, Eskenazi Health, Indianapolis, IN.
Daren M BeamDepartment of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN.
Jeffrey A KlineDepartment of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN.
Karishma S DeodharDepartment of Pharmacy, Eskenazi Health, Indianapolis, IN.
Zachary A WeberDepartment of Pharmacy, Eskenazi Health, Indianapolis, IN.
Christie M DavisDepartment of Pharmacy, Eskenazi Health, Indianapolis, IN.
Todd A WalrothDepartment of Pharmacy, Eskenazi Health, Indianapolis, IN.
Eskenazi HealthEskenazi Health Foundation · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

The Indiana EMergency Care REsearch (Indiana EMCARE) training program at Indiana University School ofMedicine (IUSM)K12HL133310 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI KROENKE, KURT · 2016 to 2020
$3.0M
NHLBI NIH HHS K12 HL133310
6 · The paper itself

Abstract

objectiveThe objective was to describe the implementation, work flow, and differences in outcomes between a pharmacist-managed clinic for the outpatient treatment of venous thromboembolism (VTE) using a non-vitamin K oral anticoagulant versus care by a primary care provider (PCP).

methodsPatients in the studied health system that are diagnosed with low-risk VTE in the emergency department are often discharged without hospital admission. These patients are treated with a non-vitamin K oral anticoagulant and follow-up either in a pharmacist-managed VTE clinic or with their PCP. Pharmacists in the VTE clinic work independently under a collaborative practice agreement (CPA). An evaluation of 34 patients, 17 in each treatment arm, was conducted to compare the differences in treatment-related outcomes of rivaroxaban when managed by a pharmacist versus a PCP.

resultsThe primary endpoint was a 6-month composite of anticoagulation treatment-related complications that included a diagnosis of major bleeding, recurrent thromboembolism, or fatality due to either major bleeding or recurrent thromboembolism. Secondary endpoints included number of hospitalizations, adverse events, and medication adherence. There was no difference in the primary endpoint between groups with one occurrence of the composite endpoint in each treatment arm (p = 1.000), both of which were recurrent thromboembolic events. Medication adherence assessment was formally performed in eight patients in the pharmacist group versus no patients in the control group. No differences were seen among other secondary endpoints.

conclusionsThe pharmacist-managed clinic is a novel expansion of clinical pharmacy services that treats patients with low-risk VTEs with rivaroxaban in the outpatient setting. The evaluation of outcomes provides support that pharmacist-managed care utilizing standardized protocols under a CPA may be as safe as care by a PCP.

Indexed as

Ambulatory Care FacilitiesAnticoagulantsCase-Control StudiesEmergency Service, HospitalFemaleHemorrhageHumansMaleMedication AdherenceMiddle AgedOutcome Assessment, Health CarePharmacistsRetrospective StudiesRivaroxabanVenous ThromboembolismAnticoagulantsRivaroxaban

Identifiers

PMID28921763
PMCPMC7089614
OpenAlexW2754788637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.